Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept

NCT01752049 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT01752049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01752049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
Lead sponsor
Unity Health Toronto
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2013
Completion date
August 30, 2019
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary hemorrhagic telangiectasia